The sleep lipid oleamide may represent an endogenous anticonvulsant: An in vitro comparative study in the 4-aminopyridine rat brain-slice model

Neuropharmacology

Volumn 46, Issue 4, 2004, Pages 541-554

  Dougalis, Antonios ^a   Lees, George ^a   Ganellin, C Robin ^b  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

4 Aminopyridine; Cannabinoids; Epilepsy; Gap junctions; Hippocampus; Neocortex; Oleamide

Indexed keywords

4 AMINOPYRIDINE; ANTICONVULSIVE AGENT; CANNABINOID RECEPTOR; CARBAMAZEPINE; CARBENOXOLONE; OLEAMIDE; PENTOBARBITAL;

ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; ATTENUATION; BRAIN SLICE; CONTROLLED STUDY; DEPOLARIZATION; DRUG EFFECT; ELECTRIC POTENTIAL; ENZYME DEGRADATION; EPILEPTIC DISCHARGE; HIPPOCAMPUS; LIPOPHILICITY; MALE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; RAT; SLEEP; TONIC SEIZURE; VISUAL CORTEX;

EID: 1242351254     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2003.10.011     Document Type: Article

References (60)

1. Anderson W.W., Collingridge G.L. The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. J. Neurosci. Methods. 108:2001;71-83.
2. Avoli M., Barbarosie M., Lucke A., Nagao T., Lopantsev V., Kohling R. Synchronous GABA-mediated potentials and epileptiform discharges in the rat limbic system in vitro. J. Neurosci. 16:1996;3912-3924.
3. Avoli M. GABA-mediated synchronous potentials and seizure generation. Epilepsia. 37:1996;1035-1042.
4. Avoli M. Do interictal discharges promote or control seizures? Experimental evidence from an in vitro model of epileptiform discharge. Epilepsia. 42:(Suppl. 3):2001;2-4.
5. Avoli M., D'Antuono M., Louvel J., Kohling R., Biagini G., Pumain R., D'Arcangelo G., Tancredi V. Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system in vitro. Prog. Neurobiol. 68:2002;167-207.
6. Barbarosie M., Avoli M. CA3-driven hippocampal-entorhinal loop controls rather than sustains in vitro limbic seizures. J Neurosci. 17:1997;9308-9314.
7. Basile A.S., Hanus L., Mendelson W.B. Characterization of the hypnotic properties of oleamide. Neuroreport. 10:1999;947-951.
8. Bruckner C., Heinemann U. Effects of standard anticonvulsant drugs on different patterns of epileptiform discharges induced by 4-aminopyridine in combined entorhinal cortex-hippocampal slices. Brain Res. 859:2000;15-20.
9. Buzsaki G., Horvath Z., Urioste R., Hetke J., Wise K. High-frequency network oscillation in the hippocampus. Science. 256:1992;1025-1027.
10. Buzsaki G. The hippocampo-neocortical dialogue. Cereb. Cortex. 6:1996;81-92.
11. Carlen P.L., Skinner F., Zhang L., Naus C., Kushnir M., Perez Velazquez J.L. The role of gap junctions in seizures. Brain Res. Rev. 32:2000;235-241.
12. + channels: local anesthetics, antiarrhythmics and anticonvulsants. Trends Pharmacol. Sci. 8:1987;57-65.
13. Catterall W.A. Cellular and molecular biology of voltage-gated sodium channels. Physiol. Rev. 72:1992;S15-S48.
14. Chiu P., Olsen D.M., Borys H.K., Karler R., Turkanis S.A. The influence of cannabidiol and delta 9-tetrahydrocannabinol on cobalt epilepsy in rats. Epilepsia. 20:1979;365-375.
15. Coulter D.A. Antiepileptic drug cellular mechanisms of action: where does lamotrigine fit in? J. Child Neurol. 12:(Suppl. 1):1997;S2-S9.
16. Coyne L., Lees G., Nicholson R.A., Zheng J., Neufield K.D. The sleep hormone oleamide modulates inhibitory ionotropic receptors in mammalian CNS in vitro. Br. J. Pharmacol. 135:2002;1977-1987.
17. Cravatt B.F., Prospero-Garcia O., Siuzdak G., Gilula N.B., Henriksen S.J., Boger D.L., Lerner R.A. Chemical characterization of a family of brain lipids that induce sleep. Science. 268:1995;1506-1509.
18. Dougalis A., Lees G. Oleamide attenuates the frequency of 4-aminopyridine (4AP)-induced spontaneous epileptiform activity in the CA3 pyramidal neurons of the rat hippocampal slice via a CB1 receptor-independent mechanism. J. Physiol. (London). 543P:2002;25P.
19. Dougalis A., Lees G. Effects of cis-Oleamide (cOA) and carbamazepine on evoked epileptiform activity induced by 4 aminopyridine (4AP) in CA1 neurons of the rat hippocampal slice. J Pharm. Pharmacol. 54P:2002;230P.
20. Dudek F.E., Patrylo P.R., Wuarin J.P. Mechanisms of neuronal synchronization during epileptiform activity. Adv. Neurol. 79:1999;699-708.
21. Edwards F.A., Konnerth A., Sakmann B., Takahashi T. A thin slice preparation for patch clamp recordings from neurones of the mammalian central nervous system. Pflugers Arch. 414:1989;600-612.
22. Fedorova I., Hashimoto A., Fecik R.A., Hedrick M.P., Hanus L.O., Boger D.L., Rice K.C., Basile A.S. Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems. J. Pharmacol. Exp. Ther. 299:2001;332-342.
23. Franks N.P., Lieb W.R. Molecular and cellular mechanisms of general anaesthesia. Nature. 367:1994;607-614.
24. Fueta Y., Avoli M. Effects of antiepileptic drugs on 4-aminopyridine- induced epileptiform activity in young and adult rat hippocampus. Epilepsy Res. 12:1992;207-215.
25. Guan X., Cravatt B.F., Ehring G.R., Hall J.E., Boger D.L., Lerner R.A., Gilula N.B. The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells. J. Cell Biol. 139:1997;1785-1792.
26. Hanus L.O., Fales H.M., Spande T.F., Basile A.S. A gas chromatographic-mass spectral assay for the quantitative determination of oleamide in biological fluids. Anal. Biochem. 270:1999;159-166.
27. Hosseinzadeh H., Nassiri A.M. Anticonvulsant, sedative and muscle relaxant effects of carbenoxolone in mice. BMC. Pharmacol. 3:2003;3.
28. Kandel A., Buzsaki G. Cellular-synaptic generation of sleep spindles, spike-and-wave discharges, and evoked thalamocortical responses in the neocortex of the rat. J. Neurosci. 17:1997;6783-6797.
29. Karler R., Turkanis S.A. The cannabinoids as potential antiepileptics. J. Clin. Pharmacol. 21:1981;S437-S448.
30. Kohling R., Gladwell S.J., Bracci E., Vreugdenhil M., Jefferys J.G. Prolonged epileptiform bursting induced by 0-Mg(2+) in rat hippocampal slices depends on gap junctional coupling. Neuroscience. 105:2001;579-587.
31. Kwan P., Sills G.J., Brodie M.J. The mechanisms of action of commonly used antiepileptic drugs. Pharmacol. Ther. 90:2001;21-34.
32. Landisman C.E., Long M.A., Beierlein M., Deans M.R., Paul D.L., Connors B.W. Electrical synapses in the thalamic reticular nucleus. J. Neurosci. 22:2002;1002-1009.
33. Leach M.J., Marden C.M., Miller A.A. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia. 27:1986;490-497.
34. Lees G., Errington A.C., Coyne L., Verdon B., Singh G., Xheng J., Nicholson R.A. The sleep hormone oleamide stereoselectively modulates both ligand gated and voltage gated channels in mammalian neurons. Fundamental and Clinical Pharmacology. 15:(Suppl. 1):2000;56. 8S04-4.
35. Lees G., Edwards M.D., Hassoni A.A., Ganellin C.R., Galanakis D. Modulation of GABA(A) receptors and inhibitory synaptic currents by the endogenous CNS sleep regulator cis-9, 10-octadecenoamide (cOA). Br. J. Pharmacol. 124:1998;873-882.
36. Li J., Shen H., Naus C.C., Zhang L., Carlen P.L. Upregulation of gap junction connexin 32 with epileptiform activity in the isolated mouse hippocampus. Neuroscience. 105:2001;589-598.
37. MacDonald R., McLean M. Anticonvulsant drugs: Mechanisms of action. Delgado-Escueta A.V., Ward A.A., Woodbury D.M., Porter R.J. Advances in Neurology. 44:1986;713-736 Raven Press, New York.
38. Margineanu D.G., Klitgaard H. Can gap-junction blockade preferentially inhibit neuronal hypersynchrony vs. excitability? Neuropharmacology. 41:2001;377-383.
39. Mechoulam R., Fride E., Hanus L., Sheskin T., Bisogno T., Di M.V., Bayewitch M., Vogel Z. Anandamide may mediate sleep induction. Nature. 389:1997;25-26.
40. Mendelson W.B., Basile A.S. The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist. Neuroreport. 10:1999;3237-3239.
41. Morisset S., Rouleau A., Ligneau X., Gbahou F., Tardivel-Lacombe J., Stark H., Schunack W., Ganellin C.R., Schwartz J.C., Arrang J.M. High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature. 408:2000;860-864.
42. Nicholson R.A., Zheng J., Ganellin C.R., Verdon B., Lees G. Anesthetic-like interaction of the sleep-inducing lipid oleamide with voltage-gated sodium channels in mammalian brain. Anesthesiology. 94:2001;120-128.
43. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2001;Academic Press, New York: Syndney.
44. Perreault P., Avoli M. Physiology and pharmacology of epileptiform activity induced by 4-aminopyridine in rat hippocampal slices. J Neurophysiol. 65:1991;771-785.
45. Perreault P., Avoli M. 4-aminopyridine-induced epileptiform activity and a GABA-mediated long-lasting depolarization in the rat hippocampus. J. Neurosci. 12:1992;104-115.
46. A receptors by barbiturates in cultured rat hippocampal neurons. J. Physiol. 497:(pt. 2):1996;509-522.
47. Ross F.M., Gwyn P., Spanswick D., Davies S.N. Carbenoxolone depresses spontaneous epileptiform activity in the CA1 region of rat hippocampal slices. Neuroscience. 100:2000;789-796.
48. Rutecki P.A., Lebeda F.J., Johnston D. 4-Aminopyridine produces epileptiform activity in hippocampus and enhances synaptic excitation and inhibition. J. Neurophysiol. 57:1987;1911-1924.
49. Schweitzer J.S., Wang H., Xiong Z.Q., Stringer J.L. pH Sensitivity of non-synaptic field bursts in the dentate gyrus. J.Neurophysiol. 84:2000;927-933.
50. Sirota A., Csicsvari J., Buhl D., Buzsaki G. Communication between neocortex and hippocampus during sleep in rodents. Proc. Natl. Acad. Sci. USA. 100:2003;2065-2069.
51. Szente M., Gajda Z., Said A.K., Hermesz E. Involvement of electrical coupling in the in vivo ictal epileptiform activity induced by 4-aminopyridine in the neocortex. Neuroscience. 115:2002;1067-1078.
52. Verdon B., Zheng J., Nicholson R.A., Ganelli C.R., Lees G. Stereoselective modulatory actions of oleamide on GABA(A) receptors and voltage-gated Na(+) channels in vitro: a putative endogenous ligand for depressant drug sites in CNS. Br. J. Pharmacol. 129:2000;283-290.
53. Wada J.A., Wake A., Sato M., Corcoran M.E. Antiepileptic and prophylactic effects of tetrahydrocannabinols in amygdaloid kindled cats. Epilepsia. 16:1975;503-510.
54. Wada J.A., Osawa T., Corcoran M.E. Effects of tetrahydrocannabinols on kindled amygdaloid seizures and photogenic seizures in Senegalese baboons, Papio papio. Epilepsia. 16:1975;439-448.
55. Wallace M.J., Martin B.R., DeLorenzo R.J. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur. J. Pharmacol. 452:2002;295-301.
56. Watts A.E., Jefferys J.G. Effects of carbamazepine and baclofen on 4-aminopyridine-induced epileptic activity in rat hippocampal slices. Br. J. Pharmacol. 108:1993;819-823.
57. White H.S. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia. 40:(Suppl. 5):1999;S2-S10.
58. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature. 410:2001;588-592.
59. Wilson R.I., Nicoll R.A. Endocannabinoid signaling in the brain. Science. 296:2002;678-682.
60. Yonekawa W.D., Kapetanovic I.M., Kupferberg H.J. The effects of anticonvulsant agents on 4-aminopyridine induced epileptiform activity in rat hippocampus in vitro. Epilepsy Res. 20:1995;137-150.